A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Pfizer
Pfizer
A2 Biotherapeutics Inc.
Adela, Inc
Elephas
Elephas
Ourotech, Inc.
A2 Biotherapeutics Inc.
Bristol-Myers Squibb
Tempus AI
Pfizer
Pfizer
DxTerity Diagnostics
Boston Scientific Corporation
Intuitive Surgical
GenomeDx Biosciences Corp
Bristol-Myers Squibb
Exact Sciences Corporation
Bristol-Myers Squibb
Aesculap AG
Bristol-Myers Squibb
SpeciCare
Innersight Labs Ltd
GlaxoSmithKline
GlaxoSmithKline
Amgen
Pfizer
Pfizer
Pfizer